Mechanism of Ⅲ in the treatment of proteinuria in chronic kidney disease: a network pharmacology-based study / 南方医科大学学报
Journal of Southern Medical University
;
(12): 227-234, 2019.
Artículo
en Chino
| WPRIM
| ID: wpr-772094
ABSTRACT
OBJECTIVE@#To identify the main active components in Ⅲ and their targets and explore the mechanism by which Ⅲ alleviates proteinuria in chronic kidney disease (CKD) based on network pharmacology.@*METHODS@#The active components of Ⅲ and their potential targets, along with the oral bioavailability and drug-like properties of each component were searched in the TCMSP database. The proteinuria-related targets were searched in the GeneCards database. The active component-target network was constructed using Cytoscape software, and the acquired information of the targets from ClueGO was used for enrichment analysis of the gene pathways.@*RESULTS@#A total of 102 active components were identified from Ⅲ. These active components acted on 126 targets, among which 69 were related to proteinuria. Enrichment analysis revealed fluid shear stress- and atherosclerosisrelated pathways as the highly significant pathways in proteinuria associated with CKD.@*CONCLUSIONS@#We preliminarily validated the prescription of Ⅲ and obtained scientific evidence that supported its use for treatment of proteinuria in CKD. The findings in this study provide a theoretical basis for further study of the mechanism of Ⅲ in the treatment of proteinuria in CKD.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Proteinuria
/
Medicamentos Herbarios Chinos
/
Farmacocinética
/
Disponibilidad Biológica
/
Química
/
Usos Terapéuticos
/
Quimioterapia
/
Insuficiencia Renal Crónica
/
Metabolismo
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Chino
Revista:
Journal of Southern Medical University
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS